...
首页> 外文期刊>BMC Oral Health >The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey
【24h】

The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey

机译:关于颌骨药物相关骨折的牙医的意识和实践及预防:横断面调查

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Accurate documentation of a patient’s prior medication use and awareness of side effects associated with anti-osteoporotic agents can assist dentists to prevent medication-related osteonecrosis of the jaw. I aimed to determine the awareness of Korean dentists regarding medication-related osteonecrosis of the jaw and the duration of drug holidays they prescribe to patients who need to undergo various dental procedures. An online, questionnaire-based survey was conducted among 1000 dentists registered in an online community in Korea. The following were determined: general characteristics; type of practice; recordkeeping regarding patients’ use of bone-modifying agents; requirement of a doctor’s referral letter; advice given regarding drug holidays of bone-modifying agents before dental surgery procedures; and experience with medication-related osteonecrosis of the jaw. Differences between dentists with and without experience in treating patients with medication-related osteonecrosis of the jaw were evaluated using the χ2 test. Although a relatively high proportion (293/1000, 29.3%) of dentists had experienced cases of medication-related osteonecrosis of the jaw, only 650/1000 (65.0%) routinely documented the type of bone-modifying agent used by patients and the duration of its use. Moreover, only 591/1000 (59.1%) dentists routinely requested referral letters from doctors before performing dental surgery on patients. Although the recommended period for a drug holiday differs for each drug, 533/1000 (53.3%) dentists did not make such a distinction. There was a statistically significant difference in the level of detail documented in terms of anti-osteoporotic drug use between dentists who had no experience in medication-related osteonecrosis of the jaw (707/1000) and those who had such experience (P?=?0.007). There was a statistically significant difference in the length of drug holidays prescribed between dentists with and without prior experience with the condition (P?=?0.001). These results suggest that dentists do not respond consistently to patients' drug history prior to performing dental procedures. This implies the need for increased cooperation between dentists and physicians, as well as the development of targeted educational interventions for the dental profession, to reduce the risk of medication-related osteonecrosis of the jaw. Not applicable.
机译:准确记录患者的先前药物使用和与抗骨质疏松剂相关的副作用的认识可以帮助牙医预防颌骨的药物相关骨折坏死。我旨在确定韩国牙医的意识,了解颌骨的药物相关骨折和毒品假期的持续时间,他们规定需要进行各种牙科手术的患者。在线,基于问卷调查的调查,在韩国在线社区注册的1000名牙医中进行了调查。以下是:一般特征;实践类型;关于患者使用骨改性剂的记录;要求医生的推荐信;在牙科手术手术前对骨改性剂的药物假期提供的建议;与颌骨相关的骨质骨折的经验。使用χ2检验评估牙医与治疗钳口药物相关骨折患者的患者的患者的差异。虽然相对较高的比例(293/1000,29.3%)牙医经历了颌骨的药物相关骨折病例,但仅650/1000(65.0%)常规记录患者使用的骨改性剂的类型和持续时间它的使用。此外,只有591/1000(59.1%)牙医在对患者进行牙科手术之前要求来自医生的推荐信。虽然药物假期的推荐期对于每种药物而异,但533/1000(53.3%)牙医没有这样的区别。在没有经验的牙医之间没有经验的牙医(707/1000)和那些经验的人(p?=? 0.007)。在牙医之间的药物假期的长度存在统计学上有显着差异,没有经验情况(p?= 0.001)。这些结果表明,在进行牙科手术之前,牙医不会始终对患者的毒品历史响应。这意味着需要增加牙医和医生之间的合作,以及针对牙科行业的有针对性教育干预的发展,以降低颌骨的药物相关骨折的风险。不适用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号